ClinicalTrials.Veeva

Menu

Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in COVID-19 Infection

Mayo Clinic logo

Mayo Clinic

Status

Completed

Conditions

Non Invasive Ventilation
High Flow Nasal Cannulla
Hypoxemic Respiratory Failure
Covid19
ARDS
Prone Positioning

Treatments

Other: Body position change

Study type

Interventional

Funder types

Other

Identifiers

NCT04694638
20-003191

Details and patient eligibility

About

This research aims to understand if prone positioning combined with high-flow nasal cannula (HFNC) or non-invasive positive pressure ventilation (NIPPV) safely reduce the rate of intubation in acute hypoxemic and/or hypercapnic respiratory failure secondary to COVID-19 infection.

Enrollment

6 patients

Sex

All

Ages

18 to 110 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with confirmed COVID19 infection or suspected COVID19 infection.
  • Patients requiring HFNC or NIPPV
  • Patients who are clinically stable and able to tolerate the changes in position that are routinely conducted as part of the standard of care in the medical ICU.
  • Patient should be able to provide informed consent to the study. Any participant speaking any language will be offered participation.
  • Able to actively participate in Assisted Manual Pronation Therapy per nursing assessment.

Exclusion criteria

Contraindication for prone positioning:

  • Intracranial pressure >30 mm Hg or cerebral perfusion pressure <60 mmHg
  • Massive hemoptysis requiring an immediate surgical or interventional radiology procedure
  • Tracheal surgery or sternotomy during the previous 15 days
  • Serious facial trauma or facial surgery during the previous 15 days
  • Deep venous thrombosis treated for less than 2 days
  • Cardiac pacemaker inserted in the last 2 days
  • Unstable spine, femur, or pelvic fractures
  • Hemodynamic instability or severe cardiac arrhythmia (chronic AFib is not a contraindication). Mean arterial pressure lower than 60 mm Hg, >1 vasopressor agent or Norepinephrine equivalent dose >0.06 mcg/kg/min
  • Pregnant women
  • Single anterior chest tube with air leaks
  • Burns on more than 20 % of the body surface
  • Delirium or altered mental status increasing fall risk while in prone position.
  • End-of-life decision before inclusion
  • Subject deprived of freedom, minor, subject under a legal protective measure
  • Unable to actively participate in Assisted Manual Pronation Therapy per nursing assessment
  • Lacking capacity to provide informed consent.
  • Individuals with mechanical or vascular disease precluding safe displacement of the head, for example: cervical spinal fusion, limited range of motion, or severe vascular occlusive disease of the head and neck.
  • Body mass index (BMI) greater than 70 kg/m2, or unable to actively participate in Assisted Manual Pronation Therapy per nursing assessment at any BMI value.

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

6 participants in 1 patient group

HFNC and NIPPV
Experimental group
Description:
Combined use of prone positioning and non-invasive positive pressure ventilation (NIPPV) and high-flow nasal cannula (HFNC)
Treatment:
Other: Body position change

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems